From Diagnostics to AI: Seegene's Technology-Sharing Vision to...
Seegene Inc., Microsoft, and Springer Nature are collaborating on a global technology-sharing initiative that combines AI-driven diagnostics and PCR technology to enhance public health infrastructure and prepare for future pandemics.
A Vision for Global Health Security
Seegene Inc., a leading South Korean molecular diagnostic company, has partnered with Microsoft and Springer Nature to work towards a "world free from diseases." This collaboration aims to improve diagnostic accessibility and drive innovation in public health. Dr. Jong-Yoon Chun, the CEO and founder of Seegene, shared the vision of this initiative at an executive roundtable on October 23 at Springer Nature’s campus in London. During the meeting, the three companies discussed Seegene’s technology-sharing initiative and the foundation it creates for global health security, including the use of Microsoft’s AI technology.
Strengthening Localized Diagnostic Capabilities
One of the main objectives of the technology-sharing initiative is to advance advanced diagnostic and data-analysis technologies through an open-innovation approach. Seegene's multiplex technology, which allows for simultaneous testing of multiple pathogens, is being shared with partner organizations worldwide. Dr. Chun envisions creating a strong network that empowers scientists globally to respond swiftly to various diseases, both human and non-human. With the increasing risks of outbreaks due to climate change, Seegene aims to contribute to a healthier ecosystem and minimize the impact of infectious diseases and cancer.
Integrating AI and Cloud Technology for Widespread Access
Dr. Chun highlighted the significance of leveraging AI, cloud computing, and next-generation sequencing to maximize the effectiveness of PCR testing and broaden its accessibility. He emphasized the importance of collaboration in ensuring that innovations in disease prevention reach everyone. Seegene's strategy includes making diagnostic tools readily available for routine use, aiming for a future where individuals can perform health checks independently.
Vision for Health Equity: PCR Tests as Accessible as Vending Machines
Seegene aims to make at-home PCR testing affordable and widely accessible, envisioning a world where individuals can conduct routine health checks independently. Dr. Chun believes that within the next decade, diagnostic testing could be as easily accessible as vending machines, easing the burden on healthcare systems and promoting health equity.
Demonstrating Advances in AI-Driven Diagnostics
Microsoft's collaboration with Seegene and Springer Nature aims to prepare for future pandemics through advanced AI-driven diagnostics. By integrating Microsoft’s AI technology into Seegene's automated product development system, the companies have made significant progress in reducing analysis time and enhancing diagnostic accuracy.
Building a Robust Global Diagnostic Network
Companies participating in this technology-sharing initiative will have access to Seegene's advanced diagnostic technology to develop syndromic real-time PCR products tailored to their countries' public health needs. This initiative promotes global scientific participation in PCR diagnostic development and aims to create accurate, rapid, and accessible tests for underserved populations.
Seegene's commitment to driving innovation in the field of diagnostics and public health readiness marks a significant step towards building a healthier and more secure future for all.
